Epigenetic function during heroin self-administration controls future relapse-associated behavior in a cell type-specific manner
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2210953120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Ethan M Anderson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425. Hauptthemen laut MEDLINE: Heroin, Cocaine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Opioid use produces enduring associations between drug reinforcement/euphoria and discreet or diffuse cues in the drug-taking environment. These powerful associations can trigger relapse in individuals recovering from opioid use disorder (OUD). Here, we sought to determine whether the epigenetic enzyme, histone deacetylase 5 (HDAC5), regulates relapse-associated behavior in an animal model of OUD. We examined the effects of nucleus accumbens (NAc) HDAC5 on both heroin- and sucrose-seeking behaviors using operant self-administration paradigms. We utilized cre-dependent viral-mediated approaches to investigate the cell-type–specific effects of HDAC5 on heroin-seeking behavior, gene expression, and medium spiny neuron (MSN) cell and synaptic physiology. We found that NAc HDAC5 functions during the acquisition phase of heroin self-administration to limit future relapse-associated behavior. Moreover, overexpressing HDAC5 in the NAc suppressed context-associated and reinstated heroin-seeking behaviors, but it did not alter sucrose seeking. We also found that HDAC5 functions within dopamine D1 receptor-expressing MSNs to suppress cue-induced heroin seeking, and within dopamine D2 receptor-expressing MSNs to suppress drug-primed heroin seeking. Assessing cell-type–specific transcriptomics, we found that HDAC5 reduced expression of multiple ion transport genes in both D1- and D2-MSNs. Consistent with this observation, HDAC5 also produced firing rate depression in both MSN classes. These findings revealed roles for HDAC5 during active heroin use in both D1- and D2-MSNs to limit distinct triggers of drug-seeking behavior. Together, our results suggest that HDAC5 might limit relapse vulnerability through regulation of ion channel gene expression and suppression of MSN firing rates during active heroin use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425.
ORCID-Profile: Ethan M Anderson, Evgeny Tsvetkov, Allison Galante, Lauren M McCue, Christopher W Cowan
Förderung
- NIGMS NIH HHS
- NIDA NIH HHS
Zitieren
APA
Anderson, E. M., Tsvetkov, E., Galante, A., DeVries, D., McCue, L. M., Wood, D., Barry, S., Berto, S., Lavin, A., Taniguchi, M., & Cowan, C. W. (2023). Epigenetic function during heroin self-administration controls future relapse-associated behavior in a cell type-specific manner. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2210953120
Vancouver
Anderson EM, Tsvetkov E, Galante A, DeVries D, McCue LM, Wood D, et al. Epigenetic function during heroin self-administration controls future relapse-associated behavior in a cell type-specific manner. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2210953120
BibTeX
@article{Anderson2023,
author = {Anderson, Ethan M and Tsvetkov, Evgeny and Galante, Allison and DeVries, Derek and McCue, Lauren M and Wood, Daniel and Barry, Sarah and Berto, Stefano and Lavin, Antonieta and Taniguchi, Makoto and Cowan, Christopher W},
title = {Epigenetic function during heroin self-administration controls future relapse-associated behavior in a cell type-specific manner},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2210953120}
}
EUVIMED